Hadi Mansour
Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
Mansour, Hadi; Slika, Hasan; Nasser, Suzanne A.; Pintus, Gianfranco; Khachab, Maha; Sahebkar, Amirhossein; Eid, Ali H.
Authors
Hasan Slika
Suzanne Nasser s.n.nasser@keele.ac.uk
Gianfranco Pintus
Maha Khachab
Amirhossein Sahebkar
Ali H. Eid
Abstract
Cardiovascular disease (CVD) remains the leading cause of global morbidity and mortality. Extensive efforts have been invested to explicate mechanisms implicated in the onset and progression of CVD. Besides the usual suspects as risk factors (obesity, diabetes, and others), the gut microbiome has emerged as a prominent and essential factor in the pathogenesis of CVD. With its endocrine-like effects, the microbiome modulates many physiologic processes. As such, it is not surprising that dysbiosis-by generating metabolites, inciting inflammation, and altering secondary bile acid signaling- could predispose to or aggravate CVD. Nevertheless, various natural and synthetic compounds have been shown to modulate the microbiome. Prime among these molecules are flavonoids, which are natural polyphenols mainly present in fruits and vegetables. Accumulating evidence supports the potential of flavonoids in attenuating the development of CVD. The ascribed mechanisms of these compounds appear to involve mitigation of inflammation, alteration of the microbiome composition, enhancement of barrier integrity, induction of reverse cholesterol transport, and activation of farnesoid X receptor signaling. In this review, we critically appraise the methods by which the gut microbiome, despite being essential to the human body, predisposes to CVD. Moreover, we dissect the mechanisms and pathways underlying the cardioprotective effects of flavonoids.
Citation
Mansour, H., Slika, H., Nasser, S. A., Pintus, G., Khachab, M., Sahebkar, A., & Eid, A. H. (in press). Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay. Pharmacological Research, 209(November 2024), 1-13. https://doi.org/10.1016/j.phrs.2024.107452
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 4, 2024 |
Online Publication Date | Oct 8, 2024 |
Deposit Date | Oct 17, 2024 |
Journal | Pharmacological Research |
Print ISSN | 1043-6618 |
Electronic ISSN | 1096-1186 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 209 |
Issue | November 2024 |
Article Number | 107452 |
Pages | 1-13 |
DOI | https://doi.org/10.1016/j.phrs.2024.107452 |
Keywords | Cardiovascular disease, Gut microbiota, Natural polyphenols, Flavonoids, Trimethylamine-N-oxide, Inflammation, Farnesoid X receptor, bile acid |
Public URL | https://keele-repository.worktribe.com/output/950541 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S1043661824003979?via%3Dihub |
You might also like
C-peptide in diabetes: A player in a dual hormone disorder?
(2024)
Journal Article
Epac as a tractable therapeutic target
(2023)
Journal Article
Inflammation and hypertension: Underlying mechanisms and emerging understandings.
(2023)
Journal Article
Factors associated with infertility among the Lebanese population: a cross-sectional study
(2023)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search